Pembrolizumab Dual Endocrine Toxicity in a Metastatic Non-small Cell Lung Cancer Patient.

Saved in:
Bibliographic Details
Title: Pembrolizumab Dual Endocrine Toxicity in a Metastatic Non-small Cell Lung Cancer Patient.
Authors: Al-Lababidi S; Internal Medicine, Saint Michael's Medical Center, Newark, USA., Alkhlaifat R; Internal Medicine, Saint Michael's Medical Center, Newark, USA., Herrera-Gonzalez M; Internal Medicine, Saint Michael's Medical Center, Newark, USA., Sunderam D; Endocrinology and Diabetes, Saint Michael's Medical Center, Newark, USA.
Source: Cureus [Cureus] 2026 Jun 01; Vol. 18 (6), pp. e110075. Date of Electronic Publication: 2026 Jun 01 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.110075